Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Bright Light Therapy on Cognitive Impairment in Major Depressive Disorder and Its Neuroimaging Mechanisms: Protocol for a Randomised Controlled Trial

NCT07508215 is registered in ClinicalTrials.gov with Peking University Sixth Hospital as lead sponsor.

NCT NCT07508215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07508215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Bright Light Therapy on Cognitive Impairment in Major Depressive Disorder and Its Neuroimaging Mechanisms: Protocol for a Randomised Controlled Trial
Lead sponsor
Peking University Sixth Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
April 10, 2026
Completion date
December 31, 2028
Enrollment
120 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bright light treatment, cognitive impairment, major depressive disorder (mdd), neuroimaging